Unknown

Dataset Information

0

Endogenous Multiple Exon Skipping and Back-Splicing at the DMD Mutation Hotspot.


ABSTRACT: Duchenne muscular dystrophy (DMD) is a severe muscular disorder. It was reported that multiple exon skipping (MES), targeting exon 45-55 of the DMD gene, might improve patients' symptoms because patients who have a genomic deletion of all these exons showed very mild symptoms. Thus, exon 45-55 skipping treatments for DMD have been proposed as a potential clinical cure. Herein, we detected the expression of endogenous exons 44-56 connected mRNA transcript of the DMD using total RNAs derived from human normal skeletal muscle by reverse transcription polymerase chain reaction (RT-PCR), and identified a total of eight types of MES products around the hotspot. Surprisingly, the 5' splice sites of recently reported post-transcriptional introns (remaining introns after co-transcriptional splicing) act as splicing donor sites for MESs. We also tested exon combinations to generate DMD circular RNAs (circRNAs) and determined the preferential splice sites of back-splicing, which are involved not only in circRNA generation, but also in MESs. Our results fit the current circRNA-generation model, suggesting that upstream post-transcriptional introns trigger MES and generate circRNA because its existence is critical for the intra-intronic interaction or for extremely distal splicing.

SUBMITTER: Suzuki H 

PROVIDER: S-EPMC5085753 | biostudies-literature | 2016 Oct

REPOSITORIES: biostudies-literature

altmetric image

Publications

Endogenous Multiple Exon Skipping and Back-Splicing at the DMD Mutation Hotspot.

Suzuki Hitoshi H   Aoki Yoshitsugu Y   Kameyama Toshiki T   Saito Takashi T   Masuda Satoru S   Tanihata Jun J   Nagata Tetsuya T   Mayeda Akila A   Takeda Shin'ichi S   Tsukahara Toshifumi T  

International journal of molecular sciences 20161013 10


Duchenne muscular dystrophy (DMD) is a severe muscular disorder. It was reported that multiple exon skipping (MES), targeting exon 45-55 of the <i>DMD</i> gene, might improve patients' symptoms because patients who have a genomic deletion of all these exons showed very mild symptoms. Thus, exon 45-55 skipping treatments for DMD have been proposed as a potential clinical cure. Herein, we detected the expression of endogenous exons 44-56 connected mRNA transcript of the <i>DMD</i> using total RNAs  ...[more]

Similar Datasets

| S-EPMC8330042 | biostudies-literature
| S-EPMC6175390 | biostudies-literature
| S-EPMC3783188 | biostudies-other
| S-EPMC7327972 | biostudies-literature
| S-EPMC11219862 | biostudies-literature
| S-EPMC4027981 | biostudies-literature
| S-EPMC10248452 | biostudies-literature
| S-EPMC9323532 | biostudies-literature
| S-EPMC6222172 | biostudies-literature
| S-EPMC3724403 | biostudies-literature